What we have learned about quality measures for intrapartum obstetrical care
This article reviews important concepts in the measurement of quality obstetrical care, and demonstrates how these concepts have been informed by the Assessment of Perinatal Excellence (APEX) study performed by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal–Fetal Medicine Units (MFMU) Network. (Source: Seminars in Perinatology)
Source: Seminars in Perinatology - May 18, 2016 Category: Perinatology & Neonatology Authors: Jennifer L. Bailit, William A. Grobman, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network Source Type: research
Cover
(Source: Seminars in Perinatology)
Source: Seminars in Perinatology - May 11, 2016 Category: Perinatology & Neonatology Source Type: research
Masthead
(Source: Seminars in Perinatology)
Source: Seminars in Perinatology - May 11, 2016 Category: Perinatology & Neonatology Source Type: research
Topics
(Source: Seminars in Perinatology)
Source: Seminars in Perinatology - May 11, 2016 Category: Perinatology & Neonatology Source Type: research
Table of Contents
(Source: Seminars in Perinatology)
Source: Seminars in Perinatology - May 11, 2016 Category: Perinatology & Neonatology Source Type: research
What we have learned about best practices for recruitment and retention in multicenter pregnancy studies
For 30 years, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network has had significant impact on clinical practice in obstetrics. The MFMU Network has conducted 50 randomized clinical trials and observational studies designed to improve pregnancy outcomes for mothers and children. Each center has a designated clinical research nurse coordinator who coordinates the day-to-day operations of each trial and leads a research team that is responsible for recruitment and retention of participants. (Source: Seminars in Perinatology)
Source: Seminars in Perinatology - May 8, 2016 Category: Perinatology & Neonatology Authors: Ashley Salazar, Susan Tolivaisa, Donna Allard, Tammy S. Bishop, Sabine Bousleiman, Kelly Clark, Wendy Dalton, Stacy Harris, Kathy Hale, Kim Hill, Francee Johnson, Gail Mallett, Lisa Moseley, Felecia Ortiz, Cynthia Willson, Elizabeth A. Thom, Eunice Kenned Source Type: research
Introduction
Every year in the United States, about four million women give birth. While the majority of pregnancies result in a safe and happy outcome for mother and baby, a significant proportion of pregnancies are at risk for adverse outcomes. For example, one in nine babies is born prematurely before 37 weeks of gestation, and has an increased risk of morbidity and death compared with babies born at term. Those born before 32 weeks of gestation have a significantly increased risk of long-term morbidity and disability such as cerebral palsy. (Source: Seminars in Perinatology)
Source: Seminars in Perinatology - May 5, 2016 Category: Perinatology & Neonatology Authors: Uma M. Reddy, George R. Saade, Elizabeth A. Thom Source Type: research
What we have learned about intrapartum fetal monitoring trials in the MFMU Network
The vast majority of pregnant women are subjected to electronic fetal heart monitoring during labor. There is limited evidence to support its benefit compared with intermittent auscultation. In addition, there is significant variability in interpretation and its false-positive rate is high. The latter may have contributed to the rise in operative deliveries. In order to address the critical need for better approaches to intrapartum monitoring, the MFMU Network has completed two large multisite randomized trials, one to evaluate fetal pulse oximetry and the other to evaluate fetal ECG ST segment analysis (STAN). (Source: Se...
Source: Seminars in Perinatology - April 28, 2016 Category: Perinatology & Neonatology Authors: Steven L. Bloom, Michael Belfort, George Saade, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Source Type: research
What we have learned about antenatal corticosteroid regimens
Administration of antenatal corticosteroids has been standard of care for women between 24 and 34 weeks of gestation who are at risk for preterm delivery for more than 20 years longer in other parts of the world. Although the benefit of steroids in this population has been confirmed, there remain many questions including the frequency of dosing and whether it is possible to expand the gestational age criteria to women likely to deliver before 24 weeks or after 34 weeks. The MFMU Network has played a major role in answering some of these questions. (Source: Seminars in Perinatology)
Source: Seminars in Perinatology - April 24, 2016 Category: Perinatology & Neonatology Authors: Ronald J. Wapner, Cynthia Gyamfi-Bannerman, Elizabeth A. Thom, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Source Type: research
What we have learned about treating mild gestational diabetes mellitus
This article will review the benefits of mild GDM treatment, and related risk factors, on short-term and long-term maternal and neonatal/child outcomes, with an emphasis on research conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal –Fetal Medicine Units Network. (Source: Seminars in Perinatology)
Source: Seminars in Perinatology - April 24, 2016 Category: Perinatology & Neonatology Authors: Madeline Murguia Rice, Mark B. Landon, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal –Fetal Medicine Units (MFMU) Network Source Type: research
What we have learned about antenatal corticosteroid regimens
Administration of antenatal corticosteroids has been standard of care for women between 24 and 34 weeks of gestation who are at risk for preterm delivery for more than 20 years longer in other parts of the world. Although the benefit of steroids in this population has been confirmed, there remain many questions including the frequency of dosing and whether it is possible to expand the gestational age criteria to women likely to deliver before 24 weeks or after 34 weeks. The MFMU Network has played a major role in answering some of these questions. (Source: Seminars in Perinatology)
Source: Seminars in Perinatology - April 24, 2016 Category: Perinatology & Neonatology Authors: Ronald J. Wapner, Cynthia Gyamfi-Bannerman, Elizabeth A. Thom, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Source Type: research
What we have learned about treating mild gestational diabetes mellitus
This article will review the benefits of mild GDM treatment, and related risk factors, on short-term and long-term maternal and neonatal/child outcomes, with an emphasis on research conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. (Source: Seminars in Perinatology)
Source: Seminars in Perinatology - April 24, 2016 Category: Perinatology & Neonatology Authors: Madeline Murguia Rice, Mark B. Landon, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units (MFMU) Network Source Type: research
